- Ethics in Clinical Research
- Patient-Provider Communication in Healthcare
- Biomedical Ethics and Regulation
- Social Media in Health Education
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical studies and practices
- Pharmaceutical Economics and Policy
- Mobile Health and mHealth Applications
- Patient Dignity and Privacy
- Management, Economics, and Public Policy
- Organ Donation and Transplantation
- Patient Safety and Medication Errors
- Acute Kidney Injury Research
- Spinal Cord Injury Research
- Medical Malpractice and Liability Issues
- Asthma and respiratory diseases
- Healthcare Decision-Making and Restraints
- Persona Design and Applications
- Digital Mental Health Interventions
- Ethics in medical practice
- Global Health and Surgery
- Respiratory viral infections research
- Cardiac Arrest and Resuscitation
- Pediatric health and respiratory diseases
- Meta-analysis and systematic reviews
Yale University
2012-2021
General Department of Preventive Medicine
2018
University of Milan
2015
Yale New Haven Hospital
1990-1997
Visual Abstract Export Background and objectives Patients are informed of the risk kidney biopsy–related complications using data from nonhospitalized patients, which may underestimate for hospitalized patients. We evaluated rate factors in patients with acute disease (AKD) to better estimate this population. Design, setting, participants, & measurements used Yale biopsy cohort evaluate rates including adjudicated procedure-related bleeding requiring blood transfusions or angiographic...
Background The traditional informed consent (IC) process rarely emphasizes research participants’ comprehension of medical information, leaving them vulnerable to unknown risks and consequences associated with procedures or studies. Objective This paper explores how we evaluated the feasibility a digital health tool called Virtual Multimedia Interactive Informed Consent (VIC) for advancing IC compared results paper-based methods IC. Methods Using web-based coaching, developed VIC that uses...
Abstract Background Although research participation is essential for clinical investigation, few quantitative outcome measures exist to assess participants’ experiences. To address this, we developed and deployed a survey at 15 NIH‐supported centers participant‐centered outcomes; report responses from 4,961 participants. Methods Survey questions addressed core aspects of the experience, including their overall rating, motivation, trust, informed consent. We describe participant...
IntroductionAs part of the precision medicine initiative, National Institutes Health/National Institute Diabetes and Digestive Kidney Diseases has proposed collecting human kidney tissue to discover novel therapeutic targets from patients with diseases. Patient attitudes on participating in biopsy−based research are largely unknown.MethodsWe evaluated toward donating among participants who had experienced a clinically indicated biopsy, through survey conducted 9 months (interquartile range,...
<sec> <title>BACKGROUND</title> The traditional informed consent (IC) process rarely emphasizes research participants’ comprehension of medical information, leaving them vulnerable to unknown risks and consequences associated with procedures or studies. </sec> <title>OBJECTIVE</title> This paper explores how we evaluated the feasibility a digital health tool called <i>Virtual Multimedia Interactive Informed Consent</i> (VIC) for advancing IC compared results paper-based methods...
Journal Article Pharmaceutical services at the 1995 Special Olympics World Games Get access Robert J. Harrison, Harrison Senior Pharmacist Drug Information Service Address reprint requests to Mr. Service, Vale-New Haven Hospital. 20 York Street. New Haven, CT 06504. Search for other works by this author on: Oxford Academic Google Scholar Sandra L. Alfano, PHARM.D., FASHP Associate Director Clinical Pharmacy Services, Department of Yale-New Hospital, American Health-System Pharmacy, Volume...